Evidence map›Paper›PMID 40032867›Full record

ArticleNature communications2025

Chiral sulfide and achiral sulfonic acid cocatalyzed enantioselective electrophilic tandem selenylation semipinacol rearrangement of allenols.

Ren-Fei Cao, Ruirui Su, Zheng-Wei Wei, Ze-Long Li, Deng Zhu, Yu-Xuan Huo, Xiao-Song Xue, Zhi-Min Chen

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ren-Fei Cao *School of Chemistry and Chemical Engineering, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, 200240, Shanghai, P. R. China.
Ruirui Su *School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study University of Chinese Academy of Sciences, 1 Sub-lane Xiangshan, 310024, Hangzhou, China.
Zheng-Wei WeiSchool of Chemistry and Chemical Engineering, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, 200240, Shanghai, P. R. China.
Ze-Long LiSchool of Chemistry and Chemical Engineering, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, 200240, Shanghai, P. R. China.
Deng ZhuSchool of Chemistry and Chemical Engineering, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, 200240, Shanghai, P. R. China.
Yu-Xuan HuoSchool of Chemistry and Chemical Engineering, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, 200240, Shanghai, P. R. China.
Xiao-Song XueSchool of Chemistry and Materials Science, Hangzhou Institute for Advanced Study University of Chinese Academy of Sciences, 1 Sub-lane Xiangshan, 310024, Hangzhou, China. xuexs@sioc.ac.cn.ORCID http://orcid.org/0000-0003-4541-8702
Zhi-Min ChenSchool of Chemistry and Chemical Engineering, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, 200240, Shanghai, P. R. China. chenzhimin221@sjtu.edu.cn.ORCID http://orcid.org/0000-0002-6988-8955

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21933004National Natural Science Foundation of China (National Science Foundation of China) 22071149National Natural Science Foundation of China (National Science Foundation of China) 22122104National Natural Science Foundation of China (National Science Foundation of China) 22193012National Natural Science Foundation of China (National Science Foundation of China) 22471158
6 · The paper itself

Abstract

A highly enantioselective electrophilic selenylation/semipinacol rearrangement of allenols has been developed, which is enabled by the cooperative catalysis of a chiral sulfide and an achiral sulfonic acid. The designed and synthesized chiral sulfide catalyst and selenylating reagent play a crucial role in enhancing both enantioselectivity and reactivity. This approach exhibits excellent regio-, chemo-, and enantioselectivity, providing access to diverse enantioenriched cyclopentanones featuring an arylselenovinyl-substituted quaternary carbon stereocenter. Furthermore, these products can be transformed into synthetically valuable alkyne, vinyl bromide, and aniline derivatives. Mechanistic studies reveal that the combination of a chiral sulfide and an achiral sulfonic acid not only facilitates the formation of catalytically active species, but also governs the enantioselectivity of the reaction. Meanwhile, density functional theory calculations disclose that four hydrogen bond interactions and a π‧‧‧π interaction are responsible for the observed enantioselectivity.

Identifiers

PMID40032867
PMCPMC11876436

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.